Sequenom (SQNM) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts SQNM Hot Sheet
Price: $2.39 --0%
Financial Fact:
Genetic analysis product sales and services: 2.78M
Today's EPS Names:
AEHR, VFS, CMTL, More
Financial Fact:
Genetic analysis product sales and services: 2.78M
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
Sequenom (NASDAQ: SQNM) reported Q2 EPS of ($0.08), $0.03 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $32.8 million versus the consensus estimate of $36.06 million.
For earnings history and earnings-related data on Sequenom (SQNM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Some Said Inflation Risks Had Become More Skewed To Upside - FOMC Minutes
- MicroVision stock tumbles on reiterated 2026 guidance
- Profound Medical raises Q3 2026 revenue outlook above estimates
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
